Trustee Elections
These are the original issues in this subcategory
- NURSING HOMES
- PRESCRIPTION DRUG PRICES
- ALZHEIMER’S DISEASE
Alzheimer's disease (AD) is the most common form of dementia. It causes problems with memory, thinking and behavior. Alzheimer’s is not a normal part of aging but age is an indicator of when this disease strikes. The vast majority of people with AD are 65 or older. However, early-onset Alzheimer’s, accounting for about 5% of all AD cases, affects patients who are in their 40’s. There is no cure for this disease which worsens as it progresses and eventually leads to death. Alzheimer's disease is now America’s sixth leading cause of death, taking the lives of an estimated 500,000 Americans each year. Alzheimer's patients live an average of 8 years after their symptoms become noticeable to others. Nearly 6 million Americans have Alzheimer’s disease today but many of these people have never been diagnosed. Our baby boom generation has reached the age when Alzheimer’s symptoms begin to appear. It is expected that by 2050, the number of AD sufferers will total at least 16 million Americans. Researchers say advancements in imaging and screening technology are now enabling earlier diagnosis of this disease, and that initiating treatment before patients experience serious loss of function may soon result in much better outcomes for sufferers of this insidious disease.
Pending legislation: S.1692 - Concentrating on High-Value Alzheimer’s Needs to Get to an End (CHANGE) Act of 2021
Sponsor: Sen. Shelley Capito (WV)
Status: Senate Committee on Finance
Chair: Sen. Ron Wyden (OR)
Pending legislation: S.1692 - Concentrating on High-Value Alzheimer’s Needs to Get to an End (CHANGE) Act of 2021
Sponsor: Sen. Shelley Capito (WV)
Status: Senate Committee on Finance
Chair: Sen. Ron Wyden (OR)
- I oppose reforming current Alzheimer’s disease policy and wish to donate resources to the campaign committee of Leader Charles Schumer (NY).
- I support providing better care and outcomes for Americans living with Alzheimer’s disease and related dementias and their caregivers while accelerating progress toward prevention strategies, disease modifying treatments, and ultimately, a cure by:
1.) Requiring the Centers for Medicare and Medicaid Services to identify a uniform, reliable cognitive impairment detection tool or set of tools that will incentivize clinicians to detect, refer and diagnose Alzheimer’s and related dementias in their earliest stages.
2.) Establishing payment measures to incentivize the detection and diagnosis of Alzheimer's disease or related dementias and discussion of appropriate care planning services, including potential for clinical trial participation.
And wish to donate resources to the campaign committee of Sen. Ron Wyden (OR) and/or to an advocate group currently working with this issue.
- I support providing better care and outcomes for Americans living with Alzheimer’s disease and related dementias and their caregivers while accelerating progress toward prevention strategies, disease modifying treatments, and ultimately, a cure by:
1.) Requiring the Centers for Medicare and Medicaid Services to identify a uniform, reliable cognitive impairment detection tool or set of tools that will incentivize clinicians to detect, refer and diagnose Alzheimer’s and related dementias in their earliest stages.
2.) Establishing payment measures to incentivize the detection and diagnosis of Alzheimer's disease or related dementias and discussion of appropriate care planning services, including potential for clinical trial participation.
And wish to donate resources to the campaign committee of Sen. Ron Wyden (OR) and/or to an advocate group currently working with this issue.
There has been $0.00 pledged in support of this issue
Trustee Election - Opening Date
October 3, 2022
Trustee Election - Closing Date
October 10, 2022